Table 4.
Factors associated with persistent HBV infection
| Baseline characteristics | RR (95% CI) | p-value | aRR (95% CI) | p-value |
|---|---|---|---|---|
| Gender (ref: female) | ||||
| Male | 1.75 (1.00–3.06) | 0.05 | 1.71 (0.97–3.02) | 0.064 |
| Research site (ref: urban) | ||||
| Rural | 0.59 (0.24–1.47) | 0.254 | 0.51 (0.17–1.52) | 0.226 |
| Age group (years) (ref: ≥35) | ||||
| < 24 | 1.46 (0.51–4.20) | 0.478 | 1.57 (0.47–5.23) | 0.463 |
| 24–34 | 1.24 (0.69–2.25) | 0.469 | 1.43 (0.79–2.61) | 0.241 |
| CD4 count (cells/mm3) (ref: ≥200) | ||||
| < 50 | 2.63 (1.10–6.32) | 0.030 | 2.54 (1.06–6.14) | 0.038 |
| 50–200 | 1.57 (0.68–3.58) | 0.289 | 1.54 (0.65–3.63) | 0.327 |
| Active TB at enrolment (ref: no) | ||||
| Yes | 1.17 (0.66–2.10) | 0.588 | 0.80 (0.42–1.52) | 0.498 |
| BMI (kg/m2) (ref: < 18.5) | ||||
| ≥ 18.5 | 1.15 (0.46–2.85) | 0.764 | 1.33 (0.54–3.28) | 0.538 |